The First CBD Oil Produced Fully In Uruguay
ICC Labs developed Bidiol, a high-quality cannabis extract available in 3%, 5% and 10% CBD formulations. After years of research and process optimization, it offers safe and effective medicinal products.
Its laboratory, located in the Science Park, has been authorized by the Ministry of Public Health (MSP) since 2018 and holds GMP and GLP certifications for the manufacturing of cannabis extracts and pharmaceutical products based on cannabis.
Evidence for the use of CBD in the treatment of other pathologies
- Autoimmune diseases (inflammation, rheumatoid arthritis) (11)
- Neurological conditions, Alzheimer's, dementia, Parkinson's, multiple sclerosis, epilepsy (2, 6)
- Neuropsychiatric illness, autism, ADHD, post-traumatic stress disorder, alcoholism (2)
- Cardioprotective (3)
- Skin disease (acne, dermatitis, psoriasis) (12, 13)
- Sleep disorders (8)
- Anxiety or depression (1)
